Organon & Co.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
OGN$13.89+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Income
($ in millions except shares in thousands and per share amounts)
| Year EndedDecember 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Revenues | $6,216 | $6,403 | $6,263 |
| Cost of sales | 2,903 | 2,688 | 2,515 |
| Gross profit | 3,313 | 3,715 | 3,748 |
| Selling, general and administrative | 1,721 | 1,760 | 1,893 |
| Research and development | 366 | 469 | 528 |
| Acquired in-process research and development and milestones | 6 | 81 | 8 |
| Goodwill impairment | 301 | — | — |
| Restructuring costs | 95 | 31 | 62 |
| Interest expense | 504 | 520 | 527 |
| Exchange losses | 14 | 26 | 42 |
| Other (income) expense, net | (119) | 21 | 15 |
| Income before income taxes | 425 | 807 | 673 |
| Income tax expense (benefit) | 238 | (57) | (350) |
| Net income | $187 | $864 | $1,023 |
| Earnings per share: | |||
| Basic | $0.72 | $3.36 | $4.01 |
| Diluted | $0.72 | $3.33 | $3.99 |
| Weighted average shares outstanding: | |||
| Basic | 259,495 | 257,046 | 255,239 |
| Diluted | 260,764 | 259,152 | 256,270 |
-62-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.